Real-world data of second-line immunotherapy in metastatic clear cell renal cell carcinoma: A retrospective study

Real-world data of second-line immunotherapy in metastatic clear cell renal cell carcinoma: A retrospective study

Background: Targeted therapies have prolonged the survival of patients with metastatic renal cell carcinomas (RCC). However, the majority of patients with metastatic RCC develop treatment resistance and disease progression. The programmed cell death protein 1 inhibitors offer a new ray of hope for s...

Full description

Bibliographic Details
Main Authors: Waseem Abbas, Anjali Aggarwal, Promila Pankaj, Rachna Jain
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2021-01-01
Series:Cancer Research, Statistics, and Treatment
Subjects:
checkpoint inhibitors
clear cell carcinoma
immunotherapy
nivolumab
renal cell carcinoma
Online Access:http://www.crstonline.com/article.asp?issn=2590-3233;year=2021;volume=4;issue=1;spage=55;epage=60;aulast=Abbas

Internet

http://www.crstonline.com/article.asp?issn=2590-3233;year=2021;volume=4;issue=1;spage=55;epage=60;aulast=Abbas

Similar Items